Charles Moore Charles Moore

Covid-19 is giving me hyper-focus on the beauty of spring

issue 18 April 2020

We know, because of the lack of widespread testing, that incidences of Covid-19 are under-reported. What is less well known is that they may be over-reported as a cause of death. In hospices and in care homes, I gather, where tests are not available, doctors are encouraged, if in doubt, to write ‘suspected Covid‑19’ on 1A of the death certificate, as the ‘primary cause’ of death. They do not wish to be accused of underplaying it. But they do not know they are right, because there have been no tests. A cough and a temperature can be enough to secure a Covid diagnosis, yet the cough could have many causes and the temperature could have come from sepsis. At the time of writing, our daily death figures are only hospital deaths. When hospice and care home ones are added, as is intended soon, can anyone know their accuracy?

A neighbour of ours, self-isolating and with poor lung function, has twice been telephoned recently by the medical authorities. After pleasant preliminaries about her health, both callers muttered something about ‘If the worst happened and you did become ill’. So she cut through: ‘Are we getting round to DNR [Do Not Resuscitate]?’ They admitted as much. My neighbour told them she did want to be resuscitated. Yes, medics might want to know these preferences, but is it right to chase old people living compulsorily alone? It casts a chill, as does the waiter who stands over you and says: ‘Have you finished yet?’

Roy Kerridge has died (not of the coronavirus). Older Spectator readers will remember his remarkable articles in the 1980s. Small, mild, myopic, in a shabby suit, Roy would have been well cast as Mole in The Wind in the Willows.

GIF Image

Disagree with half of it, enjoy reading all of it

TRY 3 MONTHS FOR $5
Our magazine articles are for subscribers only. Start your 3-month trial today for just $5 and subscribe to more than one view

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in